We have the FDA (VRBPAC) external view 77% affirmative vote.
Not sure what the 18% who voted no or 5% abstaining were thinking.
But expect final FDA EUA approval for the 1st vaccine for the US in a very short time. 👍👍👏👏
The "no" concerns about age 16-17 are not consistent with the protocol inclusion criteria, even though the number of participants < 18 were low.
The number of participants by age, 95 were age 16 or 17
If there is a biological reason for a difference in the immune response to a vaccine for a 16-year-old vs an 18-year-old, I’ll be interested to hear it.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Eric Topol

Eric Topol Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @EricTopol

14 Dec
1 down, 200+ million to go Image
Why 200+ million (not 300), and how we could get there faster
The functionality of the health system CEO in this photo is striking 😉
Read 4 tweets
13 Dec
Why 2 proline (P) substitutions will go down in history.
Introducing 2P's at the beginning of the central helix (CH) stabilized the spike protein's confirmation upon entering cells.
From the Jan 10 #SARSCoV2 sequence, this 2P Δ was incorporated into the mRNA vaccine designs /1 Image
This was a result of elegant #3D structural biology work @NIH (Barney Graham), @scrippsresearch (Andrew Ward) and collaborators from a @PNASNews paper that was rejected 5 times! pnas.org/content/114/35… /2 ImageImage
Without the 2P design, the mRNA vaccines would have failed.
The remarkable story is told well by @Carolynyjohnson
washingtonpost.com/health/2020/12… /3 ImageImage
Read 7 tweets
12 Dec
The United States has an ambitious plan to get to population level immunity, but it doesn't have the vaccines to accomplish it (no less the buy in of Americans)
@WSJgraphic by @ErikBrynildsen @joshulick @TaylorUmlauf
@toddlindeman /1
Before the vaccine problems with Sanofi-GSK (wrong dose) and Astra Zeneca/Oxford (? dose) the US was already short in covering its population
nature.com/articles/d4158… /2
Here the US ranks #32 as compared with other countries
bloomberg.com/news/articles/… @bloomberg @ArmstrongDrew @tsrandall /3
Read 11 tweets
6 Dec
Key science behind the success of the mRNA #SARSCoV2 vaccines
—A paper that was *rejected 5 times* finally published in 2017
"Full spike plus 2P" @PNASNews
pnas.org/content/114/35… w/ @scrippsresearch
—1990 @ScienceMagazine mRNA in vivo -> protein
science.sciencemag.org/content/247/49…
Important backstory of the basic science over many years that culminated in the 11 month "astonishing" success
washingtonpost.com/health/2020/12… by @Carolynyjohnson featuring @kkariko's work and @NIAIDNews Barney Graham @NIH
Meant to post the @PNAS paper (not the same one twice)
Read 4 tweets
5 Dec
10 countries, 1 outlier
That was 8; here's the 10
10 more in countries w/ >10 million population
Read 4 tweets
5 Dec
It's the 3rd hump—its apex and duration yet unknown—that is breaking the backs of America's health workforce along with the nightmarish number of new infections and fatalities recorded each day.
adapted from @COVID19Tracking data
At just over 100,000 hospitalizations, we have already past the breaking point @TheAtlantic
theatlantic.com/health/archive… @yayitsrob @alexismadrigal
We can't handle the patients now.
The ones that would be admitted.
They are getting sent home now.
New records today for cases 225,000
Hospitalizations 101, 276
and very high number of deaths 2,563
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!